
Xeloda - a drug used to treat advanced breast and colorectal cancers has been linked to fatal skin reactions, say Canadian health officials.
It said patients had reported severe skin reactions, such as the life-threatening skin condition known as Stevens?Johnson Syndrome or toxic epidermal necrolysis.
Advertisement
The signs and symptoms of this hypersensitivity include flu-like symptoms, fever, itchy skin, mouth sores, as well as painful, red or purplish skin rash that spreads and blisters, causing the top of the skin to shed, along with eye burning, itching and discharge.
Health Canada urged patients using Xeloda to contact their physician "immediately" after experiencing any of those signs or symptoms, so that they may report these adverse reactions to Roche or Health Canada.
Following requests from Canadian health authorities, Hoffmann-La Roche said it will be working with Health Canada to update the drug's prescribing information document.
It has sent a letter to healthcare professionals warning of the "risk of severe cutaneous reactions associated with the use of Xeloda," though it stressed that those cases were "very rare."
Source: AFP
Advertisement
Following requests from Canadian health authorities, Hoffmann-La Roche said it will be working with Health Canada to update the drug's prescribing information document.
It has sent a letter to healthcare professionals warning of the "risk of severe cutaneous reactions associated with the use of Xeloda," though it stressed that those cases were "very rare."
Source: AFP
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News

The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.

Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.

Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.

In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.

Women using hormonal contraception, along with their healthcare providers, should explore alternative pain relief options instead of NSAIDs.